Skip to content
Achyut Healthcare logo

Achyut Healthcare

543499 BSE
₹7.05

Close ·

P/E
352.50
View as Markdown
MCP
Close 4 Nov 2026 ₹7.05 +1.53 +27.7% 1Y
Start ₹5.52

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare

Price-based figures at the close · EPS basis: Standalone · TTM

ROCE
1.18%
Debt to Equity
0.04
EPS (TTM)
₹0.02
Book Value
₹1.46
Market Cap
—
P/E (TTM)
352.50
P/B
4.83
ROE
0.96%
Dividend Yield
0.00%
EBITDA
₹60.00 L
52W High
₹10.04
52W Low
₹4.70

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

53 Average

Data confidence 98/100

Category scores

Quality
47
Average
Returns, margins, earnings quality 22% weight
Valuation
17
Poor
Cheap vs sector & own history 24% weight
Growth
99
Strong
Sales & profit trajectory 9% weight
Financial Health
83
Strong
Solvency, leverage, coverage 9% weight
Momentum
88
Strong
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company is almost debt free.
  • Debtor days have improved from 76.8 to 45.7 days.
  • Company's working capital requirements have reduced from 515 days to 91.0 days

Weaknesses

4
  • Stock is trading at 3.95 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 1.53% over last 3 years.
  • Promoter holding has decreased over last 3 years: -6.37%

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bullish2611
OscillatorsBullish063
Moving AveragesStrong Bullish208

Key readings

RSI (14)
53.35
Neutral
MACD (12,26,9)
0.38
Bullish
SMA (50)
6.64
Bullish
SMA (200)
6.26
Bullish

As of

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.

Revenue

Revenue growth by window
5Y+112.10%
3Y+62.52%
1Y+280.00%

Net profit

Net profit growth by window
5Y+100.00%
3Y+11.64%
1Y−37.25%

Operating cash flow

Operating cash flow growth by window
5Y+157.40%
3YTurned positive
1YTurned positive

Operating margin· change in pp

Operating margin growth by window
5Y−2.23 pp
3Y+11.47 pp
1Y+6.39 pp

Trailing twelve months: Fewer than eight quarters are reported, so there is no trailing-twelve-month figure.

Revenue by year

Revenue by year, ₹ crore
Mar 2019₹0.67 Cr
Mar 2020₹0.33 Cr
Mar 2021₹0.27 Cr
Mar 2022₹4.05 Cr
Mar 2023₹2.70 Cr
Mar 2024₹6.14 Cr
Mar 2025₹3.05 Cr
Mar 2026₹11.59 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2019−₹0.01 Cr
Mar 2020₹0.01 Cr
Mar 2021₹0.01 Cr
Mar 2022₹0.04 Cr
Mar 2023₹0.23 Cr
Mar 2024₹0.50 Cr
Mar 2025₹0.51 Cr
Mar 2026₹0.32 Cr

Quarterly Results

₹ Cr
543499 quarterly results, ₹ crore
Particulars Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0
0.92
3.09
2.55
1.57
4.39
3.13
Expenses
0.13
0.87
3.02
2.47
1.58
4.37
2.95
Operating Profit
−0.13
0.05
0.07
0.08
−0.01
0.02
0.18
OPM %
—
5.43%
2.27%
3.14%
−0.64%
0.46%
5.75%
Other Income
0.18
0.18
0.08
0.11
0.04
0.14
0.05
Interest
0
0.04
0.01
0
0
0.03
0.01
Depreciation
0
0.06
0.03
0.03
0.03
0.08
0.03
PBT
0.05
0.13
0.11
0.16
0
0.05
0.19
Tax %
20%
7.69%
9.09%
31.25%
—
0%
26.32%
Net Profit
0.03
0.12
0.1
0.12
0
0.06
0.14
EPS (₹)
0
0.01
0
0.01
0
0
0.01

Profit & Loss

₹ Cr
543499 profit and loss, annual, ₹ crore
Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
0.67
0.33
0.27
4.05
2.7
6.14
3.05
11.59
11.64
Expenses
0.66
0.32
0.26
4.08
2.97
6.12
3.2
11.42
11.37
Operating Profit
0.01
0.01
0.01
−0.03
−0.27
0.02
−0.15
0.17
0.27
OPM %
1.49%
3.03%
3.7%
−0.74%
−10%
0.33%
−4.92%
1.47%
2.32%
Other Income
0
0.01
0
0.14
0.59
0.73
0.92
0.38
0.34
Interest
0
0
0
0
0
0
0.04
0.04
0.04
Depreciation
0
0
0
0.01
0.01
0.01
0.08
0.14
0.17
PBT
0.01
0.02
0.01
0.1
0.31
0.74
0.65
0.37
0.4
Tax %
300%
0%
0%
60%
25.81%
32.43%
21.54%
16.22%
—
Net Profit
−0.01
0.01
0.01
0.04
0.23
0.5
0.51
0.32
0.32
EPS (₹)
−0.01
0.01
0.01
0
0.01
0.02
0.02
0.01
0.02
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
543499 balance sheet, annual, ₹ crore
Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
0.25
0.25
0.25
6.74
9.35
16.83
23.56
24.14
Reserves
−0.05
−0.04
0
2.34
5.18
13.93
7.71
10.93
Borrowings
0
0
0
0
0
0
1.55
1.49
Other Liabilities
0.04
0.06
0.25
0.86
0.81
0.19
1.3
1.54
Total Liabilities
0.24
0.27
0.5
9.94
15.34
30.95
34.12
38.1
Fixed Assets
0
0
0
0.03
0.05
0.06
1.44
1.55
CWIP
0
0
0
0
3.49
9.16
18.29
27.88
Investments
0
0
0
1.7
1.3
0
0
0
Other Assets
0.24
0.27
0.5
8.21
10.5
21.73
14.39
8.67
Total Assets
0.24
0.27
0.5
9.94
15.34
30.95
34.12
38.1

Cash Flow

₹ Cr
543499 cash flow, annual, ₹ crore
Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
−0.03
−0.02
0.01
−6.96
−0.43
−0.36
−4
1.13
Investing
0
0
0
−1.6
−4.81
−15.23
−1.5
−2.23
Financing
0
0
0
8.79
5.21
15.72
−0.14
3.38
Net Cash Flow
−0.03
−0.02
0.01
0.24
−0.03
0.14
−5.64
2.29
Free Cash Flow
−0.03
−0.02
0.01
−6.99
−3.75
−6.37
−14.79
−7.15
CFO/EBITDA
−300
−100
100
23,100
126
−700
2,553
712

Ratios

543499 financial ratios, annual
Particulars Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
54.48
188
379
18.02
36.5
24.37
160
45.66
Inventory Days
0
0
159
14.29
59.59
3.96
24.16
15.79
Days Payable
—
—
381
41.78
55.87
12.54
145
44.43
Cash Conversion Cycle
54.48
188
156
−9.46
40.22
15.79
39.54
17.02
Working Capital Days
76.27
210
216
604
1,257
1,242
211
91.01
ROCE %
—
9.76%
4.35%
2.14%
2.63%
3.27%
2.17%
1.18%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Achyut Healthcare insights

54 extracted metrics across FY19–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 47.40%
  • Public 42.84%
  • FIIs 5.13%
  • Others 4.64%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

Frequently Asked Questions about Achyut Healthcare

What does Achyut Healthcare Ltd do?
Achyut Healthcare Ltd (formerly Achyut Healthcare Pvt Ltd; originally Achyut Securities Pvt Ltd) is an Ahmedabad-based trader in APIs, pharmaceutical products/inputs and medical devices. It is developing a formulations plant at Bhat, Ahmedabad.
Where is Achyut Healthcare Ltd (ACHYUT) listed?
Achyut Healthcare Ltd trades under code 543499 on the BSE.
Which sector does Achyut Healthcare Ltd belong to?
Achyut Healthcare Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the PE ratio of Achyut Healthcare Ltd?
Achyut Healthcare Ltd trades at a PE ratio of 352.50 as of 4 Nov 2026, on earnings per share of ₹0.02, against a book value of ₹1.46 per share.
What is the 52-week high and low of Achyut Healthcare Ltd?
Over the last 52 weeks Achyut Healthcare Ltd has traded between ₹4.7 and ₹10.04 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Achyut Healthcare Ltd?
Achyut Healthcare Ltd reported a return on equity of 0.96%. Its debt-to-equity ratio is 0.04.

Company Information

Achyut Healthcare Ltd (formerly Achyut Healthcare Pvt Ltd; originally Achyut Securities Pvt Ltd) is an Ahmedabad-based trader in APIs, pharmaceutical products/inputs and medical devices. It is developing a formulations plant at Bhat, Ahmedabad.

Website achyuthealthcare.com
Listed 30 Mar 2022
Face Value ₹1

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/543499.md for Achyut Healthcare Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month